Positive association between weight-adjusted-waist index and dementia in the Chinese population with hypertension: A cross-sectional study

DOI: https://doi.org/10.21203/rs.3.rs-2554780/v1

Abstract

Purpose

The links between obesity and dementia remain equivocal. Therefore, this study aimed to explore the association between weight-adjusted waist index (WWI), a new anthropometric indicator reflecting obesity, and dementia in the Chinese population with hypertension.

Methods

A total of 10,289 participants with hypertension were enrolled in this cross-sectional study, a subset of the China H-type hypertension registry study. WWI was calculated as waist circumference (WC) divided by the square root of bodyweight. Mini-mental state examination (MMSE) scale was performed to evaluate the cognitive function. According to educational background, different MMSE cut-off values were applied to define dementia: < 24 for participants with ≥ 7 years of education, < 20 for those with 1–6 years of education, and < 17 for illiterate participants. Multivariable linear regression and multivariable binary logistic regression analyses were conducted to assess the associations between WWI and MMSE and dementia, respectively.

Results

Overall, the mean age was 63.7 ± 9.7 years, and 49.0% were males. Multivariate linear regression analyses showed that WWI was negatively associated with MMSE (β, -1.09; 95% confidence interval [CI]: -1.24, -0.94). Consistently, multivariable binary logistic regression analyses found a positive association between WWI and the risk of dementia (odds ratio [OR], 1.45; 95% CI: 1.35, 1.56). Compared with individuals in quartile 1 of WWI, the adjusted β and OR values of WWI for MMSE and dementia were − 2.28 (95% CI: -2.62, -1.94) and 2.12 (95% CI: 1.81, 2.48), respectively. Results of smoothing curve fitting confirmed the linear association between WWI and MMSE and dementia. Subgroup analysis showed a stronger association between WWI and dementia in participants with hypertension with midday napping.

Conclusion

WWI was independently and positively associated with dementia among the population with hypertension, especially in those with midday napping. The data suggest that WWI may serve as a simple and effective tool for the assessment of the risk of dementia in clinical practice.

Introduction

An estimated 4.6 million new cases of dementia have been detected worldwide each year, and the prevalence of dementia will increase rapidly in the coming decades[1]. By 2050, approximately 85 million people are predicted to have dementia in less developed regions. Obesity is widely recognized as a risk factor for various chronic diseases such as cardiovascular disease, metabolic syndrome, stroke, diabetes, and cancer[24]. In recent years, the relationship between obesity and dementia has been increasingly reported except in China, but the conclusions are controversial. Some studies found that obesity was associated with cognitive decline[56] and increased the risk of dementia[78]. However, recent findings indicated that obesity failed to increase the risk of dementia[910], while some reported that individuals with obesity have a lower risk for dementia[1112]. One major explanation for these inconsistent findings on the obesity-dementia link may be an overreliance on body mass index (BMI) as a measure of obesity[13]. Therefore, further research on obesity should rely less on BMI or at least perform other measurements in addition to BMI.

As a new anthropometric measure reflecting fat and muscle mass components, weight-adjusted waist index (WWI) was calculated by standardizing waist circumference (WC) for bodyweight by combining the advantages of WC and weakening the correlation with BMI[14]. Existing studies have shown a better effect of WWI for predicting the risk of certain diseases (e.g., hypertension and cardiometabolic diseases) than that of WC and BMI, the most commonly used obesity indices. Furthermore, recent findings from our team also found that WWI rather than WC and BMI better predicted the risk of mortality. In other words, WWI may be a comprehensive and effective obesity index.

Therefore, the present study aimed to assess the association between WWI and the risk of dementia and examine any possible effect modifier using data from the China H-type hypertension registry study.

Methods

Study Participants

This study was a subset of the China H-type hypertension registry study (No. ChiCTR1800017274), a real-world, observational study conducted in Wuyuan county in Jiangxi province of China from March 2018 to August 2018. A detailed description of the China H-type hypertension registry study has been previously published[15]. Eligible participants were male and female individuals aged ≥ 18 years old with hypertension, excepting those with psychological or nervous system diseases resulting in an inability to demonstrate informed consent. All participants signed informed consent before entering the study. The study was approved by the Ethics Committee of Anhui Medical University Biomedical Institute (No.CH1059).

As a result, a total of 14,234 participants with hypertension were recruited for the study. After excluding participants without mini-mental state examination (MMSE) data (n = 3,945), 10,289 participants were finally included in the present cross-sectional study for analysis.

Data collection and variable definitions

Demographic information (e.g., age, sex, and education), living conditions (e.g., current smoking, current drinking, midday napping, sleeping, economic level, labor intensity, and psychological stress), dietary habit (e.g., cooking oil, bean products, meat, fruit, and vegetables), self-reported medical history (e.g., diabetes, stroke, coronary heart disease [CHD], chronic renal disease [CKD], and malignant tumor), and medication history (e.g., antihypertensive, glucose-lowering, and lipid-lowering drugs) from all participants were collected using a standard questionnaire by trained staffs.

Current smoking was defined as smoking ≥ 1 cigarette per day for 1 year or more or a cumulative smoking amount ≥ 360 cigarettes per year. Current drinking defined as drinking alcohol an average of at least two or more times a week over a year. Economic level was subjectively assessed by participants based on comparision with local residents, which included “good”, “medium”, and “poor”. Labour intensity was reflected in self-reported physical burden at work, including light labour (mild), tired or heavy labour (moderate), extremely tired or heavy labour (severe). Psychological stress was referred to the participant's anxiety and emotional tension caused by various reasons such as work problems and health problems, which included “mild”, “modrate”, and “severe”. Sleep duration was assessed by the question: “How many hours on average do you sleep per night?” Mean sleep duration was categorized into 3 groups:<5h, 5–8, and >8hours. Midday napping was assessed by asking “Did you have midday napping habit?” with the following responses: “yes”, “no”.

Physical indicators such as height, weight, and WC were measured twice, and the average values were calculated as the corresponding values. Height was measured using a standard right-angle device and a fixed vertical ruler to the nearest 0.1 cm. Bodyweight was measured using the Omron body fat and weight measurement device from Japan to the nearest 0.01 kg. WC was measured using a tape to measure the minimum circumference at the midpoint between the costal margin and iliac crests (at the umbilicus level) to the nearest 0.1 cm. Blood pressure (BP) was measured three times on the right arm positioned at the heart level using an electronic BP monitor (Omron HBP-1300; OMRON, Japan) after a rest for 5 min, with a 30 s interval between measurements, and three measurements of systolic blood pressure (SBP) and diastolic blood pressure (DBP) were averaged as the corresponding BP values for analysis. BMI was calculated as the weight (kg) divided by the squared height (m2). In addition, WWI was calculated as WC (cm) divided by the square root of weight (kg)[16].

Hypertension was defined as seated resting SBP ≥ 140 mmHg or DBP ≥ 90 mmHg or the use of antihypertensive medications at screening[17]. Diabetes mellitus was defined as a self-reported physician diagnosis of diabetes or the use of glucose-lowering drugs or fasting blood glucose (FBG) concentration ≥ 7.0 mmol/L.

Laboratory tests

Blood samples were collected after ≥ 8 h fasting and delivered to a standardized laboratory within 24 h of sampling. Laboratory indicators include plasma homocysteine (Hcy), FBG, fasting total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), uric acid (UA), and creatinine (Cr) were detected from all participants. The estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation[18]. All laboratory measurements followed a standardization and certification program.

Cognitive assessment

The cognitive function was evaluated using the Chinese version of the MMSE scale[19], which involves a broad series of cognitive domains, including language and visuospatial construction, short-term verbal memory, calculation and attention, immediate recall, and orientation. Correct answers to all questions on the MMSE scale were rated as a maximum score of 30, representing the best cognitive function level. The MMSE score < 24 for participants with secondary school or above education setting (≥ 7 years of education), < 20 for those with primary school (1–6 years of education), and < 17 for illiterate participants were defined as dementia.

Statistical analysis

Continuous variables were presented as mean ± standard deviation (SD), and categorical variables were expressed as frequency (n) and percentage (%). The characteristic differences by WWI quartiles were contrasted using one-way analysis of variance (ANOVA) tests for continuous variables or Chi-square tests for categorical variables. The associations between WWI and MMSE and dementia were analyzed using multivariable linear regression and multivariable binary logistic regression, respectively. In addition, the results were described as β coefficients and odds ratios (ORs) with 95% confidence intervals (CIs). We conducted three levels of adjustment models for the regression analysis: model 1was adjusted for none; model 2 was adjusted for age and sex; and model 3 was adjusted for age, sex, BMI, SBP, DBP, Hcy, FPG, TC, TG, HDL-C, LDL-C, UA, eGFR, diabetes, stroke, CHD, CKD, malignant tumor, antihypertensive drugs, glucose-lowering drugs, lipid-lowering drugs, current smoking, current drinking, midday napping, sleeping duration, economic level, labor intensity, psychological stress, cooking oil, bean products, meat, fruits, and vegetables. These covariables adjusted in the regression models were selected due to clinical importance, statistical significance in the univariable analysis, and the potential confounder effect estimates individually changed by at least 10%. Dose-response relationship between WWI and MMSE and dementia were evaluated using a generalized additive model (GAM) and a fitted smoothing curve (penalized spline method). Additionally, possible modifications of the association with dementia were evaluated using stratified analyses and interaction testing.

R statistical package (http://www.r-proje.ct.org) and Empower (R) software (www.empow.erstats.com) were used for statistical analyses. Statistical significance was defined as a two-tailed P < 0.05.

Results

Basic characteristics

The basic characteristics of 10,289 participants grouped by WWI quartiles are shown in Table 1. Overall, the mean (SD) age was 63.7 (9.7) years old, and 49.0% were males. The mean ± SD values of WWI, WC, and BMI were 11.1 ± 0.8 cm/√kg, 84.0 ± 10.0 cm, and 23.6 ± 3.5 kg/m2, respectively. Participants with higher WWI were more likely to be older, females, have higher BMI, WC, SBP, DBP, FPG, TC, TG, LDL-C, UA, lower Hcy, HDL-C, eGFR, MMSE score (including MMSE subscores), a higher rate of diabetes, use of antihypertensive and glucose-lowering drugs, a lower proportion of current smokers, drinkers, a weaker labor intensity, and less weekly intake of bean products and meat (all P < 0.05).

Table 1

Baseline characteristics of participants stratified by quartiles of WWI

Characteristics

Total

WWI, cm/kg

 

Q1

(≥ 6.3,<10.6)

Q2

(≥ 10.6,<11.1)

Q3

(≥ 11.1,<11.6)

Q4

(≥ 11.6,<25.8)

P-value

N

10289

2570

2574

2572

2573

 

Age, years

63.7 ± 9.7

62.3 ± 10.0

62.3 ± 10.1

63.9 ± 9.2

66.6 ± 9.0

< 0.001

Male, n(%)

5039 (49.0)

1741 (67.7)

1550 (60.2)

1154 (44.9)

594 (23.1)

< 0.001

Physical examination

           

BMI, kg/m2

23.6 ± 3.5

21.6 ± 3.2

23.4 ± 3.2

24.3 ± 3.2

25.0 ± 3.6

< 0.001

WC, cm

84.0 ± 10.0

75.2 ± 7.9

82.9 ± 7.8

86.6 ± 7.8

91.1 ± 8.8

< 0.001

SBP, mmHg

147.0 ± 17.6

144.8 ± 17.6

146.2 ± 17.4

147.5 ± 17.5

149.4 ± 17.5

< 0.001

DBP, mmHg

88.8 ± 10.8

87.3 ± 10.5

89.0 ± 11.0

89.2 ± 10.5

89.8 ± 11.0

< 0.001

WWI, cm/kg

11.1 ± 0.8

10.1 ± 0.4

10.8 ± 0.1

11.3 ± 0.1

12.1 ± 0.6

< 0.001

Laboratory results

           

Hcy (µmol/L)

18.1 ± 11.4

18.9 ± 12.3

18.1 ± 11.3

17.8 ± 11.8

17.4 ± 10.0

< 0.001

FPG (mmol/L)

6.2 ± 1.6

5.9 ± 1.3

6.1 ± 1.5

6.3 ± 1.7

6.4 ± 1.8

< 0.001

TC (mmol/L)

5.1 ± 1.1

5.0 ± 1.1

5.0 ± 1.1

5.2 ± 1.1

5.2 ± 1.1

< 0.001

TG (mmol/L)

1.8 ± 1.3

1.5 ± 1.1

1.8 ± 1.3

2.0 ± 1.3

2.1 ± 1.3

< 0.001

HDL-C (mmol/L)

1.5 ± 0.4

1.6 ± 0.4

1.5 ± 0.4

1.5 ± 0.4

1.5 ± 0.4

< 0.001

LDL-C (mmol/L)

2.9 ± 0.8

2.7 ± 0.7

2.9 ± 0.8

3.0 ± 0.8

3.1 ± 0.8

< 0.001

UA (µmol/L)

429.1 ± 121.0

425.5 ± 119.4

435.1 ± 122.0

428.6 ± 123.9

427.0 ± 118.3

0.024

eGFR ( mL/min/1.73 m2 )

86.0 ± 19.7

86.2 ± 20.3

87.0 ± 19.7

86.7 ± 18.8

84.0 ± 19.7

< 0.001

Cognitive Function

           

Language and visual

-spatial skills

7.0 ± 1.7

7.4 ± 1.7

7.3 ± 1.7

6.9 ± 1.7

6.3 ± 1.6

< 0.001

Short-term verbal memory

1.9 ± 1.2

2.0 ± 1.2

2.0 ± 1.2

1.9 ± 1.2

1.7 ± 1.3

< 0.001

Calculation and attention

2.7 ± 2.0

3.1 ± 1.9

3.0 ± 1.9

2.7 ± 1.9

2.1 ± 1.9

< 0.001

Immediate recall

2.3 ± 1.0

2.5 ± 0.9

2.4 ± 1.0

2.3 ± 1.0

2.1 ± 1.1

< 0.001

Orientation

8.1 ± 2.3

8.6 ± 2.0

8.5 ± 2.0

8.0 ± 2.3

7.3 ± 2.5

< 0.001

MMSE

22.0 ± 6.4

23.6 ± 5.8

23.2 ± 6.1

21.8 ± 6.4

19.5 ± 6.5

< 0.001

Dementia

3102 (30.1)

550 (21.4)

623 (24.2)

790 (30.7)

1139 (44.3)

< 0.001

Medical history, n (%)

           

Diabetes

1898 (18.4)

306 (11.9)

426 (16.6)

547 (21.3)

619 (24.1)

< 0.001

Stroke

762 (7.4)

196 (7.6)

196 (7.6)

190 (7.4)

180 (7.0)

0.806

CHD

598 (5.8)

142 (5.5)

138 (5.4)

152 (5.9)

166 (6.5)

0.346

CKD

613 (6.0)

180 (7.0)

141 (5.5)

148 (5.8)

144 (5.6)

0.076

Malignant tumor

126 (1.2)

34 (1.3)

36 (1.4)

32 (1.2)

24 (0.9)

0.445

Medication history, n (%)

           

Antihypertensive drugs

6416 (62.4)

1536 (59.8)

1554 (60.4)

1635 (63.6)

1691 (65.7)

< 0.001

Glucose-lowering drugs

513 (5.0)

68 (2.6)

107 (4.2)

159 (6.2)

179 (7.0)

< 0.001

Lipid-lowering drugs

380 (3.7)

74 (2.9)

99 (3.8)

105 (4.1)

102 (4.0)

0.086

Living conditions

           

Current smoking, n (%)

2700 (26.2)

918 (35.7)

794 (30.8)

603 (23.4)

385 (15.0)

< 0.001

Current drinking, n (%)

2220 (21.6)

729 (28.4)

678 (26.3)

509 (19.8)

304 (11.8)

< 0.001

Midday napping, n (%)

5503 (53.5)

1401 (54.5)

1399 (54.4)

1359 (52.8)

1344 (52.2)

0.270

Sleeping duration, n (%)

           

<5h

429 (4.2)

109 (4.2)

93 (3.6)

103 (4.0)

124 (4.8)

0.341

5-8h

5308 (51.6)

1330 (51.8)

1339 (52.0)

1348 (52.4)

1291 (50.2)

 

>8h

4552 (44.2)

1131 (44.0)

1142 (44.4)

1121 (43.6)

1158 (45.0)

 

Economic level, n (%)

         

0.162

Good

1344 (13.1)

317 (12.3)

353 (13.7)

360 (14.0)

314 (12.2)

 

Medium

6946 (67.5)

1761 (68.5)

1743 (67.7)

1717 (66.8)

1725 (67.0)

 

Poor

1999 (19.4)

492 (19.1)

478 (18.6)

495 (19.2)

534 (20.8)

 

Labour intensity , n (%)

         

< 0.001

Mild

5844 (56.8)

1315 (51.2)

1440 (55.9)

1480 (57.5)

1609 (62.5)

 

Moderate

2333 (22.7)

645 (25.1)

618 (24.0)

578 (22.5)

492 (19.1)

 

Severe

2112 (20.5)

610 (23.7)

516 (20.0)

514 (20.0)

472 (18.3)

 

Psychological stress, n (%)

         

0.099

Mild

6855 (66.6)

1678 (65.3)

1753 (68.1)

1719 (66.8)

1705 (66.3)

 

Moderate

2514 (24.4)

630 (24.5)

595 (23.1)

640 (24.9)

649 (25.2)

 

Severe

920 (8.9)

262 (10.2)

226 (8.8)

213 (8.3)

219 (8.5)

 

Dietary habit

           

Cooking oil, n (%)

         

0.235

Only vegetable oil

1996 (19.4)

481 (18.7)

472 (18.3)

508 (19.8)

535 (20.8)

 

Mainly vegetable oil

6815 (66.2)

1724 (67.1)

1738 (67.5)

1685 (65.5)

1668 (64.8)

 

Mainly animal oil

1478 (14.4)

365 (14.2)

364 (14.2)

379 (14.7)

370 (14.4)

 

Bean products, n (%)

         

< 0.001

Barely

6853 (66.6)

1635 (63.6)

1608 (62.5)

1740 (67.7)

1870 (72.7)

 

1–2 times per week

2529 (24.6)

684 (26.6)

698 (27.1)

624 (24.3)

523 (20.3)

 

≥3 times per week

907 (8.8)

251 (9.8)

268 (10.4)

208 (8.1)

180 (7.0)

 

Meat, n (%)

         

< 0.001

Barely

2829 (27.5)

644 (25.1)

633 (24.6)

719 (28.0)

833 (32.4)

 

1–2 times per week

2855 (27.7)

701 (27.3)

690 (26.8)

695 (27.0)

769 (29.9)

 

≥3 times per week

4605 (44.8)

1225 (47.6)

1251 (48.6)

1158 (45.0)

971 (37.7)

 

Fruits and vegetables, n (%)

         

0.727

≤ 1.5kg per week

1664 (16.2)

432 (16.8)

407 (15.8)

403 (15.7)

422 (16.4)

 

>1.5kg per week

8625 (83.8)

2138 (83.2)

2167 (84.2)

2169 (84.3)

2151 (83.6)

 
Data are presented as n (percentage), mean ± standard deviation. BMI, Body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; WWI, weight-adjusted waist index; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; UA, uric acid; eGFR, estimated glomerular filtration rate; CHD, coronary heart disease; CKD: chronic renal disease


Association between WWI, BMI and dementia

Overall, a significant linear association between WWI and MMSE score and the risk of dementia was presented in the smoothing curve (Fig. 1a and b). For 1 unit increment in WWI, the MMSE score was changed by -1.09 (95% CI: -1.24, -0.94) according to the estimation from regression β coefficients. In addition, the OR for the risk of dementia was 1.45 (95% CI: 1.35, 1.56).

As shown in Table 2, a negative association between WWI and MMSE score was detected in all models (models 1–3) after adjusting for potential confounders. When WWI was assessed as quartiles, in the final adjusted model (model 3), the adjusted β of WWI on MMSE for participants in quartiles 2, 3, and 4 were − 0.62 (95% CI: -0.92, -0.33), -1.31 (95% CI: -1.63, -1.00), and − 2.28 (95% CI: -2.62, -1.94), respectively, compared with those in quartile 1 (P for trend < 0.001). The negative association between WWI and the scores in the five domains of MMSE was presented in Supplementary Table 1. In Table 3, compared with participants in the quartile 1, the adjusted ORs of WWI on dementia for participants in the quartiles 2, 3, and 4 were 1.29 (95% CI: 1.11, 1.49), 1.56 (95% CI: 1.34, 1.81), and 2.12 (95% CI: 1.81, 2.48), respectively. Meanwhile, the P for trend in all models was significant, indicating a dose-response relationship between WWI and MMSE score and dementia.

Table 2

Association of WWI with MMSE in different models

WWI

MMSE, β(95%CI)

Model 1

Model 2

Model 3

Continuous

-2.02 (-2.17, -1.87)

-0.72 (-0.86, -0.57)

-1.09 (-1.24, -0.94)

Quartiles

     

Q1 (≥ 6.3, <10.6)

0.00

0.00

0.00

Q2 (≥ 10.6, <11.1)

-0.39 (-0.73, -0.06)

-0.04 (-0.34, 0.27)

-0.62 (-0.92, -0.33)

Q3 (≥ 11.1, <11.6)

-1.81 (-2.15, -1.47)

-0.50 (-0.81, -0.19)

-1.31 (-1.63, -1.00)

Q4 (≥ 11.6, <25.8)

-4.14 (-4.48, -3.80)

-1.40 (-1.72, -1.07)

-2.28 (-2.62, -1.94)

P for trend

<0.001

< 0.001

<0.001

Model 1: adjusted none
Model 2: adjusted age, sex
Model 3: adjusted age, sex, BMI, SBP, DBP, Hcy, FPG, TC, TG, HDL-C, LDL-C, UA, eGFR, diebetes, stroke, CHD, CKD, malignant tumor, antihypertensive drugs, glucose-lowering drugs, lipid-lowering drugs, current smoking, current drinking, midday napping, sleeping duration, economic level, labour intensity, psychological stress, cooking oil, bean products, meat, fruits and vegetables.
Table 3

Association of WWI with dementia in different models

WWI

Dementia,OR(95%CI)

Model 1

Model 2

Model 3

Continuous

1.76 (1.66, 1.87)

1.25 (1.18, 1.33)

1.45 (1.35, 1.56)

Quartiles

     

Q1 (≥ 6.3, <10.6)

1.00

1.00

1.00

Q2 (≥ 10.6, <11.1)

1.17 (1.03, 1.34)

1.06 (0.92, 1.22)

1.29 (1.11, 1.49)

Q3 (≥ 11.1, <11.6)

1.63 (1.44, 1.85)

1.18 (1.03, 1.35)

1.56 (1.34, 1.81)

Q4 (≥ 11.6, <25.8)

2.92 (2.58, 3.30)

1.53 (1.34, 1.75)

2.12 (1.81, 2.48)

P for trend

< 0.001

<0.001

<0.001

Model 1: adjusted none
Model 2: adjusted age, sex
Model 3: adjusted age, sex, BMI,SBP, DBP, Hcy, FPG, TC, TG, HDL-C, LDL-C, UA, eGFR, diebetes, stroke, CHD, CKD, malignant tumor, antihypertensive drugs, glucose-lowering drugs, lipid-lowering drugs, current smoking, current drinking, midday napping, sleeping duration, economic level, labour intensity, psychological stress, cooking oil, bean products, meat, fruits and vegetables.


However, BMI was positively associated with MMSE score (Supplemental Table 2, β:0.15, 95%CI:0.11, 0.19), and negatively associated with dementia ( Supplemental Table 3, OR:0.95, 95%CI:0.94, 0.97 ).

Subgroup analyses

Stratified analyses were performed to evaluate the effect of WWI (per 1 unit increment) on dementia in various subgroups (Fig. 2). A significant interaction was found in the subgroup of midday napping (P for interaction < 0.05), and a stronger association between WWI and dementia was found in participants with midday napping, whereas in the other subgroups, such as sex (male vs. female), age (< 65 vs. ≥ 65 y), BMI (< 24 vs. ≥ 24 kg/m2), current smoking (no vs. yes), current drinking (no vs. yes), economic level (good vs. medium vs. poor), labor intensity (mild vs. moderate vs. severe), psychological stress (mild vs. moderate vs. severe), sleeping duration (< 5 vs. 5–8 vs. > 8 h), diabetes (no vs. yes), and CHD (no vs. yes), consistent association were observed (all P for interaction > 0.05).

Discussion

This cross-sectional population-based study suggested that WWI, a new obesity index, was independently associated with dementia. There was a linear negative association between WWI and MMSE score and a linear positive association between WWI and dementia. In addition, a stronger association between WWI and dementia was found among participants with midday napping than those without midday napping.

Several previous studies regarding the relationship between obesity and cognitive function showed inconsistent results. A longitudinal study conducted on adults with hypertension reported that a greater degree of adiposity, as measured by BMI, is independently associated with slower cognitive decline[20]. Similarly, we found that BMI was negatively associated with dementia. However, another longitudinal study revealed that obesity defined using BMI in middle age increased the risk of cognitive impairment in old age. Other research showed a null association between BMI and recognition performance[10, 21]. In addition, Luchsinger et al. confirmed that the relationship between BMI and dementia was U-shaped in a prospective study[22]. Those complex and inconsistent results are largely owing to overreliance on BMI as a measure of obesity. BMI is not a suitable measure for reflecting the impact of obesity on cognitive performance in adults. Recently, many researchers used imaging examinations to explore the effects of obesity on cognitive performance. An observational study conducted by Yoon et al. in Korean older adult populations used computed tomography (CT) scanning to measure adipose tissue and demonstrated that higher adiposity was associated with poorer cognitive performance[23]. Additionally, a significant inverse correlation between visceral adipose tissue measured by magnetic resonance imaging (MRI) and cognition has been reported by Isaac et al[24]. Obesity is represented by excess accumulation of fat in adipose tissue, and imaging examinations are the “gold standard” for the evaluation of adipose tissue. Nevertheless, imaging examinations to assess obesity are often too costly, limiting its extensively clinical application.

Our study used WWI, a new surrogate index of obesity, to explore the association between obesity and dementia. Our findings agreed well with the results obtained by imaging examinations, which quantitatively estimate the fat in adipose tissue to reflect obesity status directly[23, 24]. Most previous works on obesity on cognitive impairment and dementia were limited by overreliance on BMI as an index to define obesity rather than specific body fat and muscle mass measures. Aging is accompanied by increased body fat and reduces lean mass without overall weight loss. However, BMI cannot discriminate between fat and lean mass and has limited value in capturing these age-related changes in older adults[25, 26]. Of note, studies have indicated that reduced lean mass was associated with a higher risk of dementia[27, 28]. WC is a simple and powerful anthropometric index for abdominal fat, which is better at reflecting visceral obesity than that of BMI[29]. A prospective study performed by Cho et al. investigated the association between WC and dementia in Korean older adults, reporting that a significantly higher risk of dementia is associated with abdominal obesity measured by WC[30]. However, although WC can reflect regional fat distribution, it is highly correlated with BMI[31]. WWI, calculated as WC divided by the square root of weight, assesses adiposity by standardizing WC for weight. Thus, it may combine the advantages of WC and attenuate the association with BMI. Studies have shown that WWI is highly related to all-cause and cardiovascular mortality, hypertension, and metabolic status[16,32−34]. Kim et al. used bioelectrical impedance analysis, dual-energy X-ray absorptiometry, and abdominal computed tomography to measure body composition, confirming that WWI was negatively correlated with muscle mass and positively correlated with adipose tissue in Korean older adults[35]. Further study indicated that WWI could assess muscle and fat mass in multi-ethnic populations[36]. Therefore, WWI is a suitable anthropometric index to investigate the impact of obesity on dementia.

The present finding that obesity impacts cognitive outcomes may be involved multiple potential mechanisms. One of the mechanisms may be that excess adipose tissue, as an endocrine organ, releases large amounts of inflammatory cytokines, including interleukin-6 and tumor necrosis factor-α[37, 38]. Moreover, interleukin-6 stimulates the release of C-reactive protein from the liver[39]. Such inflammatory factors have been demonstrated to exert a detrimental impact on cognitive performance[40, 41]. Another plausible mechanism is involved in obesity-linked leptin resistance. Leptin, a hormone produced by adipose tissue, was reported to exert beneficial effects on cognitive function[42]. However, adipose tissue expansion leads to a higher level of circulating leptin, resulting in a high level of leptin resistance[43]. Furthermore, other possible mechanisms were proposed, including impaired cerebral metabolism[44], vascular endothelial damage[45], insulin resistance[46], and neuronal degradation[47].

The implication of midday napping on the dementia was inconsistently reported. A longitudinal study conducted in cognitively unimpaired older individuals found that daytime napping was independently associated with slower cognitive decline[48]. Another cohort study indicated the cross-sectional association between longer napping duration and poorer cognitive function in the elderly[49]. One of crucial reasons for these differences could be due to neglect of the nighttime sleep quality and duration. In the present study, we found that there was a stronger association between WWI and dementia among participants with midday napping, and they experienced longer sleep duration and better sleep quality. A recent publication by Leng et al. suggested that people with longer sleep duration and higher sleep efficiency have a greater risk of cognitive impairment with midday napping[50], which was consistent with our findings. Midday napping may affect cognition indirectly through total sleep duration[5152]. Finally, long-term midday napping might result in a sedentary lifestyle and impaired social communication, both of which were related to cognitive decline.

Our study has several strengths, including the large sample size study design. To our knowledge, this is the first time to evaluate the potential relationship between WWI and dementia in China. In our analysis, we explore the dose-response association between WWI and dementia using GAM and penalized spline method. An advantage over previous studies on factors affecting dementia is that our study considered the effects of some new covariates, including sleeping, midday napping, labor intensity, psychological stress, and diet on dementia. We focused on the impact of life behaviors on dementia, and we found that WWI was more strongly associated with dementia in participants with midday napping than those without midday napping.

Nevertheless, several limitations should be considered. First, our participants were Chinese people with hypertension, which may limit the generalizability of our findings to other populations. Second, the casual relationship between WWI and dementia will be elucidated by the further prospective cohort studies rather than the present cross-sectional study. Third, although we analysed the data basing on a large sample, more than a quarter of total participants randomly missed data of MMSE. Finally, although various covariates were adjusted, residual confounding may still be possible.

Conclusions

In summary, we found a linear positive association between WWI and dementia in the Chinese population with hypertension. The data suggest that WWI may serve as a simple and effective tool for the assessment of the risk of dementia in daily clinical practice.

Abbreviations

WWI Weight-adjusted waist index

WC Waist circumference

MMSE Mini-mental state examination

BM IBody mass index

CHD Coronary heart disease

CKD Chronic renal disease

BP Blood pressure

SBP Systolic blood pressure

DBP Diastolic blood pressure

FBG Fasting blood glucose

Hcy Homocysteine

TC Total cholesterol

TG Triglycerides

HDL-C High-density lipoprotein cholesterol

LDL-C Low-density lipoprotein cholesterol

UA Uric acid

Cr Creatinine

eGFR Estimated glomerular filtration rate

CKD-EPI Chronic Kidney Disease Epidemiology Collaboration

CT Computed tomography

MRI Magnetic resonance imaging

SD Standard deviation

CI Confidence interval

OR Odds ratio

ANOVA One-way analysis of variance

GAM Generalized additive model

Declarations

Acknowledgements

The authors are grateful to all research staffs and participants who participated in the Chinese Hypertension Survey. We would like to thank Editage (www.editage.com) for English language editing.

Authors’ contributions

Wei Zhou and Yanyou Xie conducted data analysis and wrote the manuscript. Huihui Bao and Xiaoshu Cheng conceived and designed the study. Chao Yu and Lingling Yu critically reviewed the manuscript for the intellectual content. All authors read and approved the final manuscript.

Funding

This work was supported by grants from Science and technology project of Education Department of Jiangxi Province (No. GJJ210193).

Availability of data and materials

The datasets analyzed in the present study will be available from the corresponding author upon reasonable request.

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Anhui Medical University Biomedical Institute (Approved No. of ethic committee: CH1059). The study was carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from the participants.

Consent for publication

Not applicable.

Competing interests

All authors declare no competing interests.

References

  1. Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull 2008;29(2 Suppl):S143-72.
  2. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009;53(21):1925-32.
  3. Ramos-Nino ME, MacLean CD, Littenberg B. Association between prevalence of obstructive lung disease and obesity: results from The Vermont Diabetes Information System. Asthma Res Pract 2021; 7(1):6.
  4. Freisling H, Arnold M, Soerjomataram I, O'Doherty MG, Ordóñez-Mena JM, Bamia C, Kampman E, Leitzmann M, Romieu I, Kee F, et al. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe. Br J Cancer 2017 ;116(11):1486-97.
  5. Gunstad J, Spitznagel MB, Paul RH, Cohen RA, Kohn M, Luyster FS, Clark R, Williams LM, Gordon E. Body mass index and neuropsychological function in healthy children and adolescents. Appetite 2008;50(2-3):246-51.
  6. Waldstein SR, Katzel LI. Interactive relations of central versus total obesity and blood pressure to cognitive function. Int J Obes 2006; 30(1):201-7..
  7. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011; 10(9):819-28.
  8. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol 2014;13(8):788-94.
  9. Albanese E, Davis B, Jonsson PV, Chang M, Aspelund T, Garcia M, Harris T, Gudnason V, Launer LJ. Overweight and Obesity in Midlife and Brain Structure and Dementia 26 Years Later: The AGES-Reykjavik Study. Am J Epidemiol 2015;181(9):672-9.
  10. Aslan AK, Starr JM, Pattie A, Deary I. Cognitive consequences of overweight and obesity in the ninth decade of life? Age Ageing 2015 ;44(1):59-65.
  11. de Bruijn RF, Bos MJ, Portegies ML, Hofman A, Franco OH, Koudstaal PJ, Ikram MA. The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC Med 2015;13:132.
  12. Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K, Evans SJW, Pocock SJ. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol 2015;3(6):431-6.
  13. Rothman, KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond) 2008; 32 (Suppl. S3):S56–S59.
  14. Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep 2018;8(1):16753.
  15. Li M, Zhan A, Huang X, Hu L, Zhou W, Wang T, Zhu L, Bao H, Cheng X. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type Hypertension Registry Study. Cardiovasc Diabetol 2020;19(1):139.
  16. Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep 2018;8(1):16753.
  17. Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, Shao L, Tian Y, Dong Y, Zheng C, et al. China Hypertension Survey Investigators. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation 2018;137(22):2344-56.
  18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150(9):604-12.
  19. Li H, Jia J, Yang Z. Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study. J Alzheimers Dis 2016; 53(2):487-496.
  20. Zhang J, Tang G, Xie H, Wang B, He M, Fu J, Shi X, Zhang C, Huo Y, Xu X, et al. Higher Adiposity Is Associated With Slower Cognitive Decline in Hypertensive Patients: Secondary Analysis of the China Stroke Primary Prevention Trial. J Am Heart Assoc 2017;6(10):e005561.
  21. Deckers K, Van Boxtel MPJ, Verhey FRJ, Köhler S. Obesity and Cognitive Decline in Adults: Effect of Methodological Choices and Confounding by Age in a Longitudinal Study. J Nutr Health Aging 2017;21(5):546-53.
  22. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007;64(3):392-8.
  23. Yoon DH, Choi SH, Yu JH, Ha JH, Ryu SH, Park DH. The relationship between visceral adiposity and cognitive performance in older adults. Age Ageing 2012;41(4):456-61.
  24. Isaac V, Sim S, Zheng H, Zagorodnov V, Tai ES, Chee M. Adverse Associations between Visceral Adiposity, Brain Structure, and Cognitive Performance in Healthy Elderly. Front Aging Neurosci 2011; 3(12):12.
  25. Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013; 93(1):359-404.
  26. Hainer V, Aldhoon-Hainerová I. Obesity paradox does exist. Diabetes Care 2013; 36 Suppl 2 (Suppl 2):S276-S281.
  27. Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol 2010;67(4):428-33.
  28. Amigues I, Schott AM, Amine M, Gelas-Dore B, Veerabudun K, Paillaud E, Beauchet O, Rolland Y, Canouï Poitrine F, Bonnefoy M. Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: the prospective EPIDOS study. J Am Med Dir Assoc 2013;14(5):352-7.
  29. Nazare JA, Smith J, Borel AL, Aschner P, Barter P, Van Gaal L, Tan CE, Wittchen HU, Matsuzawa Y, Kadowaki T, et al. Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). Am J Cardiol 2015;115(3):307-15.
  30. Cho GJ, Hwang SY, Lee KM, Choi KM, Hyun Baik S, Kim T, Han SW, Yoo HJ. Association Between Waist Circumference and Dementia in Older Persons: A Nationwide Population-Based Study. Obesity (Silver Spring) 2019;27(11):1883-91.
  31. Bouchi R, Asakawa M, Ohara N, Nakano Y, Takeuchi T, Murakami M, Sasahara Y, Numasawa M, Minami I, Izumiyama H, et al. Indirect measure of visceral adiposity 'A Body Shape Index' (ABSI) is associated with arterial stiffness in patients with type 2 diabetes. BMJ Open Diabetes Res Care 2016;4(1):e000188.
  32. Ding C, Shi Y, Li J, Li M, Hu L, Rao J, Liu L, Zhao P, Xie C, Zhan B, et al. Association of weight-adjusted-waist index with all-cause and cardiovascular mortality in China: A prospective cohort study. Nutr Metab Cardiovasc Dis 2022;32(5):1210-17.
  33. Li Q, Qie R, Qin P, Zhang D, Guo C, Zhou Q, Tian G, Liu D, Chen X, Liu L, et al. Association of weight-adjusted-waist index with incident hypertension: The Rural Chinese Cohort Study. Nutr Metab Cardiovasc Dis 2020;30(10):1732-41.
  34. Abolnezhadian F, Hosseini SA, Alipour M, Zakerkish M, Cheraghian B, Ghandil P, Cheraghpour M. Association Metabolic Obesity Phenotypes with Cardiometabolic Index, Atherogenic Index of Plasma and Novel Anthropometric Indices: A Link of FTO-rs9939609 Polymorphism. Vasc Health Risk Manag 2020;16:249-56.
  35. Kim NH, Park Y, Kim NH, Kim SG. Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults. Age Ageing 2021;50(3):780-6.
  36. Kim JY, Choi J, Vella CA, Criqui MH, Allison MA, Kim NH. Associations between Weight-Adjusted Waist Index and Abdominal Fat and Muscle Mass: Multi-Ethnic Study of Atherosclerosis. Diabetes Metab J 2022.
  37. Mohamed-Ali V, Flower L, Sethi J, Hotamisligil G, Gray R, Humphries SE, York DA, Pinkney J. beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab 2001;86(12):5864-9.
  38. Pedersen M, Bruunsgaard H, Weis N, et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 2003; 124(4):495-502.
  39. Yap SH, Moshage HJ, Hazenberg BP, Roelofs HM, Bijzet J, Limburg PC, Aarden LA, van Rijswijk MH. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochim Biophys Acta 1991;1091(3):405-8.
  40. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61(1):76-80.
  41. Teunissen CE, van Boxtel MP, Bosma H, Bosmans E, Delanghe J, De Bruijn C, Wauters A, Maes M, Jolles J, Steinbusch HW, et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 2003;134(1-2):142-50.
  42. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009;302(23):2565-72.
  43. Zhao S, Zhu Y, Schultz RD, Li N, He Z, Zhang Z, Caron A, Zhu Q, Sun K, Xiong W, et al. Partial Leptin Reduction as an Insulin Sensitization and Weight Loss Strategy. Cell Metab 2019;30(4):706-19.
  44. Volkow ND, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Alia-Klein N, Logan J, Wong C, Thanos PK, Ma Y, et al. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring) 2009;17(1):60-5.
  45. Arshad N, Lin TS, Yahaya MF. Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism. CNS Neurol Disord Drug Targets 2018; 17(8):595-603.
  46. Cholerton B, Baker LD, Craft S. Insulin, cognition, and dementia. Eur J Pharmacol 2013; 719(1-3):170-179.
  47. Smith E, Hay P, Campbell L, Trollor JN. A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes Rev 2011;12(9):740-55.
  48. Keage HA, Banks S, Yang KL, Morgan K, Brayne C, Matthews FE. What sleep characteristics predict cognitive decline in the elderly? Sleep Med 2012;13:886-892. doi: 10.1016/j.sleep.2012.02.003.
  49. Cross N, Terpening Z, Rogers NL, Duffy SL, Hickie IB, Lewis SJ, et al. Napping in older people 'at risk' of dementia: relationships with depression, cognition, medical burden and sleep quality. J Sleep Res 2015;24:494-502. doi: 10.1111/jsr.12313.
  50. Leng Y, Redline S, Stone KL, Ancoli-Israel S, Yaffe K. Objective napping, cognitive decline, and risk of cognitive impairment in older men. Alzheimers Dement 2019;15:1039-1047. doi: 10.1016/j.jalz.2019.04.009.
  51. Richards A, Inslicht SS, Metzler TJ, Mohlenhoff BS, Rao MN, O'Donovan A, et al. Sleep and Cognitive Performance From Teens To Old Age: More Is Not Better. Sleep 2017;40:zsw029. doi: 10.1093/sleep/zsw029.
  52. Kronholm E, Sallinen M, Era P, Suutama T, Sulkava R, Partonen T. Psychomotor slowness is associated with self-reported sleep duration among the general population. J Sleep Res 2011;20:288-297.doi: 10.1111/j.1365-2869.2010.00899.x.